Navigation Links
Pharmagen Announces Food and Drug Administration Registration
Date:11/6/2013

SILVER SPRING, Md., Nov. 6, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCQB: PHRX) (the "Company" or "Pharmagen") announces that it has completed the registration of Pharmagen Laboratories with the Food and Drug Administration ("FDA"). Since the tragic fungal meningitis outbreak associated with New England Compounding Center (NECC) in late 2012, Pharmagen recognizes the need for FDA's oversight of the sterile compounding industry. In an effort to embrace the pending changes in compounding pharmacy regulation, Pharmagen's registration with the FDA moves the Company closer to full cGMP compliance – including adherence to Federal Statutes 21 CFR Parts 11, 210, and 211.

Since September, Pharmagen has brought in cGMP compliance expert Kymanox to review the Company's laboratory operations. Pharmagen has also hired a full-time cGMP, Director of Compliance, that served a similar role at Teva Pharmaceuticals.  The Company anticipates hiring a second, full-time, cGMP compliance professional before the end of the year. Pharmagen, in conjunction with Kymanox and other outside advisors, has formulated a strategic plan designed to keep the Company on a path to becoming a leader in compounding cGMP compliance.

"The meningitis outbreak changed the industry and we welcome the FDA's oversight of sterile compounding. The FDA sets the world standard for quality; we are embracing cGMP and are ready to augment our current USP standards. Pharmagen has always wanted to set the standard for quality and cGMP sets the bar high. It's a great thing for our patients and shareholders," said Mackie A. Barch, CEO of Pharmagen.

About Pharmagen

Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc., Pharmagen Distribution, LLC and Pharmagen Nutraceuticals, Inc. offers innovative solutions to the nations sterile pharmaceutical crisis.  With a multi-solution approach, Pharmagen is helping to meet the demand of the health provider market through independent wholesale, compounding, and IT solutions.  Nationally focused, Pharmagen is a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins.  Pharmagen currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers' production shortages.

Contact:  888-264-4597 or info@pharmagenrx.com  
Follow Us on Twitter: @pharmagenrx or
The Drug Shortage Report  http://drugshortagereport.blogspot.com/

About Kymanox
Kymanox is a premier technical products and project management services organization. They are experts in providing clientele in the Biotech, Pharma, Device, and Nano industries with engineering, scientific, regulatory, and process operations support.

Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Pharmagen actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Pharmagen's filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Pharmagen herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Pharmagen disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Pharmagen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmagen Announces Shift In Growth Strategy
2. CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators
3. Pharmagen Announces First Quarter 2013 Results
4. Pharmagen to Present Strategic Vision for Solving Nations Parenteral Drug Shortage Crisis at 2013 BIO International Convention
5. Pharmagen Laboratories Remains Industry Leader on Patient Safety
6. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
7. Pharmagen Announces Year-End Financial Results
8. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
9. NxStage Announces Fourth Quarter 2013 Investor Conference Schedule
10. Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress
11. GSI Group Announces Financial Results for the Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):